CELL SOURCE, INC. 2019 EQUITY INCENTIVE PLAN STOCK OPTION AGREEMENTStock Option Agreement • November 13th, 2020 • Cell Source, Inc. • Pharmaceutical preparations • Nevada
Unless otherwise defined herein, the terms defined in the Cell Source, Inc. 2019 Equity Incentive Plan (the “Plan”) shall have the same defined meanings in this Stock Option Agreement (this “Option Agreement” or “Agreement”).
CELL SOURCE, INC.Convertible Note • November 13th, 2020 • Cell Source, Inc. • Pharmaceutical preparations • New York
This Convertible Note (the “Note”) is issued by Cell Source, Inc., a Nevada corporation (the “Company”), effective as of the xxth day of October 2020 (the “Issuance Date”), to _____________ (the “Lender”) pursuant to the exemptions from registration under the Securities Act of 1933.
CELL SOURCE, INC. (the “Corporation”)Stock Option Agreement • November 13th, 2020 • Cell Source, Inc. • Pharmaceutical preparations
Unless otherwise defined herein, the terms defined in the Cell Source, Inc. 2019 Equity Incentive Plan, including the 2019 Israeli Equity Incentive Sub-Plan (together hereinafter the “Plan”) shall have the same defined meanings in this Stock Option Agreement (this “Option Agreement” or “Agreement”).
